BIVIW · Biovie Inc.
Substantial doubt about the company's ability to continue as a going concern.
“Although management continues to pursue the Company’s strategic plans, there is no assurance that the Company will be successful in obtaining sufficient financing on terms acceptable to the Company, if at all, to fund continuing operations. These circumstances raise substantial doubt on the Company’s ability to continue as a going concern. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.”View the 10-K filed Aug 13, 2026
Price & Indicators
The closing range uses available history since Jul 24, 2026; less than a full year is stored.
Up next
Technicals
trend & momentum for long-term holders illustrative — not investment adviceIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
KPI extraction has been attempted, but no publishable series is available from the examined filings. This is not evidence that the company reports no KPIs.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
BIVIW
this stock
Biovie Inc.
|
$11.01M | — | — | — | — |
|
VRTX
Vertex Pharmaceuticals Inc
|
$134.22B | +16.8% | +46.2% | 30.8 | 1.7% |
|
MRNA
Moderna, Inc.
|
$85.50B | +626.2% | +4.3% | — | 8.2% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$84.33B | +5.4% | +20.8% | 20.3 | 2.1% |
|
CSLLY
Csl Ltd
|
$66.80B | — | — | — | 0.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every section- % held
- 50.5%
- Reported
- 5 of 41
- Top holder
- Diametric Capital, LP
- Filed
- Sep 28, 2026
- This year
- 11
BioVie Inc. will hold its annual meeting on November 10, 2026, seeking approval of six director elections, EisnerAmper LLP for the fiscal year ending June 30, 2027, and an increase in plan shares from 399,509 to 3,100,000.
ViewPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| BIVIW | +17.9% | +11.9% | — | +4.6% | — |
| SPY | -0.1% | +1.3% | +5.6% | +1.3% | +13.3% |
| vs SPY | +18.0% | +10.6% | — | +3.3% | — |